Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babak Boroojerdi

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|December 5, 2012
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFERPeter A LeWitt, Babak Boroojerdi, Erwin Surmann, et al.
Parkinsonism & Related Disorders|December 3, 2014
Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's diseaseNir Giladi, Liesbet Ghys, Erwin Surmann, et al.
Journal of Parkinson'S Disease|April 11, 2016
Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc AnalysisNir Giladi, Mahnaz Asgharnejad, Lars Bauer, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 31, 2003
Repetitive transcranial magnetic stimulation of the parietal cortex transiently ameliorates phantom limb pain-like syndromeRudolf Töpper, Henrik Foltys, Ingo G Meister, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2005
Task-dependent intracortical inhibition is impaired in focal hand dystoniaCathrin M Bütefisch, Babak Boroojerdi, Robert Chen, et al.
Clinical Neuropharmacology|October 3, 2007
Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson diseasePeter A LeWitt, Babak Boroojerdi, Douglas MacMahon, et al.
The European Journal of Neuroscience|May 21, 2009
The dorsal premotor cortex orchestrates concurrent speech and fingertapping movementsIngo G Meister, Dorothee Buelte, Mario Staedtgen, et al.
Journal of the Neurological Sciences|June 1, 2025
Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE studyKimiaki Utsugisawa, Masayuki Masuda, Babak Boroojerdi, et al.
Clinical Neuropharmacology|June 21, 2005
Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early-stage idiopathic Parkinson diseaseWerner M Güldenpfennig, Kathryn H Poole, Kenneth W Sommerville, et al.
Clinical Neuropharmacology|August 1, 2009
High doses of rotigotine transdermal patch: results of an open-label, dose-escalation trial in patients with advanced-stage, idiopathic Parkinson diseaseIvan Rektor, Tomislav Babic, Bernard Boothmann, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Journal of Neural Transmission (Vienna, Austria : 1996)|December 5, 2012
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFERPeter A LeWitt, Babak Boroojerdi, Erwin Surmann, et al.
Parkinsonism & Related Disorders|December 3, 2014
Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's diseaseNir Giladi, Liesbet Ghys, Erwin Surmann, et al.
Journal of Parkinson'S Disease|April 11, 2016
Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc AnalysisNir Giladi, Mahnaz Asgharnejad, Lars Bauer, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 31, 2003
Repetitive transcranial magnetic stimulation of the parietal cortex transiently ameliorates phantom limb pain-like syndromeRudolf Töpper, Henrik Foltys, Ingo G Meister, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2005
Task-dependent intracortical inhibition is impaired in focal hand dystoniaCathrin M Bütefisch, Babak Boroojerdi, Robert Chen, et al.
Clinical Neuropharmacology|October 3, 2007
Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson diseasePeter A LeWitt, Babak Boroojerdi, Douglas MacMahon, et al.
The European Journal of Neuroscience|May 21, 2009
The dorsal premotor cortex orchestrates concurrent speech and fingertapping movementsIngo G Meister, Dorothee Buelte, Mario Staedtgen, et al.
Journal of the Neurological Sciences|June 1, 2025
Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE studyKimiaki Utsugisawa, Masayuki Masuda, Babak Boroojerdi, et al.
Clinical Neuropharmacology|June 21, 2005
Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early-stage idiopathic Parkinson diseaseWerner M Güldenpfennig, Kathryn H Poole, Kenneth W Sommerville, et al.
Clinical Neuropharmacology|August 1, 2009
High doses of rotigotine transdermal patch: results of an open-label, dose-escalation trial in patients with advanced-stage, idiopathic Parkinson diseaseIvan Rektor, Tomislav Babic, Bernard Boothmann, et al.
Pageof 7